Veterinary Point Of Care Diagnostics Market Size Forecast From 2026 To 2030: Key Industry Trends

Veterinary Point Of Care Diagnostics Market Report

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

#Veterinary Point Of Care Diagnostics Market Size, Value And Growth Trajectory Through 2030#_x000D_

The veterinary point of care diagnostics market has experienced rapid growth in recent years. This market is projected to expand from $2.01 billion in 2025 to $2.28 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.4%. Historically, this growth can be attributed to the increasing prevalence of infectious and metabolic diseases in animals, the expansion of veterinary clinics and hospitals, a growing awareness of animal health, advancements in diagnostic reagents and kits, and a rising companion animal population._x000D_

_x000D_

The veterinary point of care diagnostics market size is anticipated to expand substantially over the coming years. This sector is projected to reach $3.75 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.3%. This expansion during the forecast period is propelled by factors such as the wider uptake of portable diagnostic analyzers, the incorporation of AI and IoT into veterinary diagnostics, the rise of home care veterinary solutions, increased investment in veterinary point-of-care research and development, and the broadening of molecular and biochemical diagnostic technologies. Significant trends for the forecast period encompass a growing reliance on rapid diagnostic instruments, an escalating need for on-site testing capabilities, the enhancement of companion animal health monitoring, the integration of real-time data into veterinary care practices, and the progression of preventive veterinary diagnostics._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=8238&type=smp&name=Veterinary%20Point%20Of%20Care%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Point Of Care Diagnostics Market Opportunity Drivers: What’s Unlocking New Revenue Potential?#_x000D_

A rising number of companion animals is anticipated to drive the expansion of the veterinary point-of-care diagnostics market. These are pets that reside alongside humans. The increasing companion animal population consequently fuels the demand for veterinary point-of-care diagnostics, which enables faster clinical decision-making across diagnostic, treatment selection and monitoring, and prognosis processes, as well as in operational decision-making and resource utilization. This diagnostic approach aids the growing companion animal populace by offering quick and accurate health assessments, facilitating timely treatment and better overall pet care. For instance, in March 2025, the American Pet Products Association, a US-based National Pet Products Trade Association, reported that 94 million U.S. households owned at least one pet, a significant rise from 82 million in 2023, reflecting sharp growth in companion animal adoption. Thus, the increasing companion animal population is a substantial contributor to the veterinary point-of-care diagnostics market growth._x000D_

_x000D_

#Veterinary Point Of Care Diagnostics Market Segment Trends And Revenue Contributors#_x000D_

The veterinary point of care diagnostics market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Consumables, Reagents And Kits, Instruments And Devices_x000D_

2) By Animal Type: Companion Animals, Livestock Animals_x000D_

3) By Disease: Infectious Diseases, Metabolic Diseases, Other Diseases_x000D_

4) By Technology: Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Other Technologies_x000D_

5) By End User: Veterinary Clinics, Veterinary Hospitals And Academic Institutes, Home Care Settings_x000D_

_x000D_

Subsegments:_x000D_

1) By Consumables: Test Strips, Blood Collection Tubes, Urine Test Strips, Microbial Culture Media_x000D_

2) By Reagents And Kits: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, PCR Reagents, Rapid Test Kits, Diagnostic Assay Kits_x000D_

3) By Instruments And Devices: Portable Analyzers, Diagnostic Imaging Devices, Hematology Analyzers, Biochemical Analyzers_x000D_

_x000D_

#Veterinary Point Of Care Diagnostics Market Innovation Trends Shaping Future Development#_x000D_

Major companies operating within the veterinary point-of-care diagnostics market are introducing novel assays to secure a competitive advantage. Assays are understood as diagnostic procedures or tests crafted to identify specific biological markers, substances, or conditions associated with a particular disease or health status. For instance, in September 2023, Zomedica Corp., a US-based veterinary health company, released a new assay, endogenous ACTH (eACTH), intended for equine plasma and usable on its TRUFORMA In-Clinic Biosensor Testing Platform. This innovation empowers equine veterinarians to conveniently diagnose and manage Cushing’s Disease (pituitary pars intermedia dysfunction – PPID) directly within the clinic or at the stall. The eACTH assay offers reference lab-level accuracy, proving beneficial in the diagnosis and oversight of horses affected by PPID, a prevalent endocrine disorder in equines. Zomedica’s objective is to cater to the distinct requirements of equine practitioners, fostering both patient and practice health with the TRUFORMA diagnostic platform._x000D_

_x000D_

#Veterinary Point Of Care Diagnostics Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_

Major companies operating in the veterinary point of care diagnostics market are IDEXX Laboratories Inc., Heska Corporation, Eurolyser Diagnostica GmbH, Anipoc Ltd., Alvedia, Bionote Inc., Mindray Bio‑Medical Electronics Co. Ltd., Thermo Fisher Scientific Inc., BioGal Galed Labs, MEGACOR Diagnostik GmbH, GeneReach, Quidel Corporation, Biopanda Reagents Ltd., Biochek BV, IDvet, Skyla Corporation, Fassisi GmbH, GE Healthcare, Esaote SpA, BioMerieux SA, Prometheus Bio Inc., Midland BioProducts _x000D_

_x000D_

#View The Full Veterinary Point Of Care Diagnostics Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/veterinary-point-of-care-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Veterinary Point Of Care Diagnostics Market Regional Outlook: Where Is Opportunity Concentrated?#_x000D_

North America was the largest region in the veterinary point of care diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary point of care diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model